Question 1

What is the catalog number for SB-202190, p38 MAP kinase inhibitor?

Accepted Answer

The catalog number for SB-202190, p38 MAP kinase inhibitor is TBI2172-10MG.

Question 2

What sizes are available for SB-202190, p38 MAP kinase inhibitor?

Accepted Answer

SB-202190, p38 MAP kinase inhibitor is available in the following size(s): 10 mg.

Question 3

Is SB-202190, p38 MAP kinase inhibitor in stock?

Accepted Answer

SB-202190, p38 MAP kinase inhibitor is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What host species was used to raise this antibody?

Accepted Answer

The host species used in production is listed under product specifications on the datasheet, and is relevant when selecting a compatible secondary antibody for your assay.

Question 5

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Question 6

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

SB-202190, p38 MAP kinase inhibitor

Product Specifications

Bioactivity

Shipping Conditions

Frequently Asked Questions

Explore Other Products

Human IgG Immunoglobulin (IG266), CF647 conjugate, 0.1mg/mL

CD59 (heavy chain of Protectin) (BRA-10G), CF488A conjugate, 0.1mg/mL

Eosinophil Peroxidase (AHE-1), CF740 conjugate, 0.1mg/mL

CD47 (B6H12.2), CF405S conjugate, 0.1mg/mL

CD16 (C16/1045), CF640R conjugate, 0.1mg/mL

Mucin 1 / EMA / Episialin / CD227 (VU-2G7), CF640R conjugate, 0.1mg/mL